CD36: a promising therapeutic target in hematologic tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD36: a promising therapeutic target in hematologic tumors

Published:2024-07-09 Issue: Volume: Page:1-17
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Yue Ningning¹,Jin Qiqi¹,Li Cuicui¹,Zhang Litian¹,Cao Jiajia¹,Wu Chongyang¹^ORCID

Affiliation:

1. Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China

Funder

National Natural Science Foundation of China

Scientific Research Project of Gansu Province

‘CuiYing postgraduate tutor’ training program of Lanzhou University Second Hospital

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2376178

Reference130 articles.

1. CD36, a scavenger receptor implicated in atherosclerosis

2. The role of CD36 receptor in the pathogenesis of atherosclerosis

3. CD36 Is Palmitoylated on Both N- and C-terminal Cytoplasmic Tails

4. Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat Metabolism

5. CD36 as a double-edged sword in cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP